(Q50569430)

English

Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin.

scientific article published on 21 December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/18179454

Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin. (English)

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/18179454

0 references

1 reference

based on heuristic

inferred from title

pegylated interferon

1 reference

based on heuristic

inferred from title

author name string

M Núñez

1

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/18179454

A Ocampo

2

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/18179454

K Aguirrebengoa

3

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/18179454

M Cervantes

4

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/18179454

A Pascual

5

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/18179454

S Echeverria

6

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/18179454

V Asensi

7

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/18179454

P Barreiro

8

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/18179454

J Garcia-Samaniego

9

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/18179454

V Soriano

10

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/18179454

PRESCO Team

11

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/18179454

publication date

21 December 2007

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/18179454

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/18179454

15

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/18179454

5

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/18179454

363-369

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/18179454

American Gastroenterological Association technical review on the management of hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00952.X

21 January 2018

Severe anemia following combined alpha-interferon/ribavirin therapy of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00952.X

21 January 2018

Definition and management of anemia in patients infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00952.X

21 January 2018

Evidence that plasma concentration rather than dose per kilogram body weight predicts ribavirin-induced anaemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00952.X

21 January 2018

Early monitoring of ribavirin plasma concentrations may predict anemia and early virologic response in HIV/hepatitis C virus-coinfected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00952.X

21 January 2018

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00952.X

21 January 2018

Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00952.X

21 January 2018

Factors contributing to ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00952.X

21 January 2018

Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00952.X

21 January 2018

Anemia associated with antiviral therapy in chronic hepatitis C: incidence, risk factors, and impact on treatment response.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00952.X

21 January 2018

Natural history of anemia associated with interferon/ribavirin therapy for patients with HIV/HCV coinfection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00952.X

21 January 2018

Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00952.X

21 January 2018

Impact of ribavirin dose reductions in hepatitis C virus genotype 1 patients completing peginterferon alfa-2a/ribavirin treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00952.X

21 January 2018

Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00952.X

21 January 2018

Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alpha

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00952.X

21 January 2018

Identifiers

10.1111/J.1365-2893.2007.00952.X

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/18179454

release_guz4mm4o4zg47orfi4p7wq5jbe

1 reference

https://api.fatcat.wiki/v0/release/guz4mm4o4zg47orfi4p7wq5jbe

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/18179454

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50569430&oldid=1843058507"